UCB Articles
UCB sells Somatostatine to Eumedica
16 February 2009
Stock Commentary - Europe - week to Feb 9, 2009
16 February 2009
UCB targets FDA Cimzia RA response in 2nd qtr
16 February 2009
Cypress gains FDA approval for generic Keppra
26 January 2009
Roxane's generic Keppra cleared in USA
26 January 2009
Azur buys four drugs from UCB
19 January 2009
Enrollment complete in Ph III trial of Jazz' fibromyalgia drug
19 January 2009
UCB expands discovery accord with BioSeek
19 January 2009
Wilex jumps 43% on alliance with UCB
19 January 2009
FDA asks UCB to solve Neupro formulation
12 January 2009
Anti-epileptics to get suicide warnings in USA
22 December 2008
Cambridge Laboratories' tetrabenazine approved in Spain
15 December 2008
Stock Commentary - Europe - week to Nov 24, 2008
1 December 2008
Jazz/UCB drug meets endpoints in Ph III trial
1 December 2008
Cimzia plus MTX inhibits RA joint damage
1 December 2008
Mylan gets final OK for Keppra generic
10 November 2008
US FDA approves Pfizer's Toviaz
10 November 2008
UCB presents data from two Ph III Cimzia trials
3 November 2008
Pfizer and UCB form UK joint venture to speed up drug discovery
27 October 2008
UCB launches Vimpat in UK
20 October 2008
Stock Commentary - Europe - week to Oct 13, 2008
20 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
UCB's Cimzia improves Crohn's lesions
13 October 2008
Belgium launches pharma R&D campaign
6 October 2008
UCB withdraws Vimpat application to EMEA
6 October 2008
Stock Commentary - New York week to Sept 22, 2008
29 September 2008
Stock Commentary - Europe - week to Sept 22, 2008
29 September 2008
Perrigo gets rights to allergy drug from Synthon
15 September 2008
US FDA calls for tougher warnings on TNF-alpha drugs on 240 cases of histoplasmosis
15 September 2008
UCB to cut 17% of staff in major restructuring
8 September 2008
US FDA set for even fewer approvals in 2008
1 September 2008
Stock Commentary - Europe - week to Aug 11, 2008
18 August 2008
UCB shares fall 8.3% as FDA rejects Vimpat for DNP
4 August 2008
UCB's Cimzia under review for active RA
7 July 2008
Vimpat gets nod for epilepsy from CHMP
7 July 2008
Ph IIa results for UCB's lacosamide positive but fate of drug rests on further analysis
30 June 2008
UCB report is cagey about interim results
26 May 2008
Stock Commentary - Europe - week to May 5, 2008
12 May 2008
UCB
28 April 2008
UCB's lacosamide cuts neuropathic pain
28 April 2008
UCB drops 12% on Neupro batches recall
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
FDA issues warning on UCB's cough medicine
24 March 2008
Two firms named for breach of UK Code of Practice
17 March 2008
UCB's Cimzia effective in treatment refractory CD
10 March 2008
UCB makes executive appointments
10 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
UCB's 2007 net profit down 59% on M&A
10 March 2008
Xyzal oral solution cleared by US FDA
25 February 2008
GSK another to cut back in France
11 February 2008
Teva enters drug alliance with UCB in USA
21 January 2008
Stock Commentary - Europe - week to Jan 7, 2008
14 January 2008
UCB raises guidance for 2008 above consensus
24 December 2007
CHMP issues negative view on Cimzia in Crohn's
26 November 2007
Japanese generic drug listings for November
21 November 2007
Cimzia plus MTX inhibits joint damage in RA
19 November 2007
Cimzia maintains remission in CD for up to 18 months
5 November 2007
UCB initiates Ph III trials of brivaracetam
5 November 2007
UCB opens Irish production plant
15 October 2007
UCB's Neupro effective for motor impairment in PD
15 October 2007
UCB settles US Keppra patent suit
15 October 2007
Asche Chiesi and Janssen-Cilag to co-market asthma drugs
27 September 2007
Stock Commentary - Europe - week to August 27, 2007
3 September 2007
Stock Commentary - Europe - week to August 6, 2007
13 August 2007
Stock Commentary - Europe - week to July 30, 2007
6 August 2007
Schwarz' 1st-half net profit falls 30%
6 August 2007
UCB's 1st-half profits fall 39% on Schwarz buy
6 August 2007
USB appoints Detlef Thielgen as CFO
23 July 2007
Strong Ph III data on UCB's Cimzia in NEJM
23 July 2007
Stock Commentary - Europe - week to July 16, 2007
23 July 2007
Neupro patch for PD patients in the USA
23 July 2007
Brivaracetam effective in epilepsy, says UCB
23 July 2007
Forthcoming meetings and conferences
16 July 2007
FDA OKs UCB/Sanofi's Xyzal for allergies
4 June 2007
UCB's Cimzia shows efficacy at 80 weeks
28 May 2007
Cimzia key drug in UCB 2007 R&D update
7 May 2007
UCB's Keppra effective in infant seizure study
30 April 2007
Stock Commentary - Europe - week to April 23, 2007
30 April 2007
Stock Commentary - Europe - week to April 9
16 April 2007
Stock Commentary - Europe - week to March 26
2 April 2007
Delay likely for UCB's Cimzia in Crohn's
2 April 2007
Keppra gets FDA OK as PGCT seizure therapy
26 March 2007
France's LEEM co-opts four members
19 March 2007
EC approves UCB's Xyrem
19 March 2007
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
